Recombinant Human Growth Hormone (JintropinSeries)

Human Growth Hormone (hGH) is a peptide hormone secreted by the anterior pituitary gland of the human body. It stimulates tissues such as the liver to produce insulin-like growth factor (IGF-1) to exert its physiological functions, promoting bone growth, protein Synthesis, and regulating fat, sugar, mineral metabolism, etc., which plays an important role in human growth and development.

Recombinant human growth hormone has become one of the important products produced by modern biotechnology. At present, it is mainly used for the slow growth of children caused by endogenous growth hormone deficiency, with global sales of approximately $ 5 billion. Based on the current situation, the overall scale of China's recombinant human growth hormone industry is not large compared with developed countries in Europe and the United States, , and the domestic market potential is huge in the future.

In 2018 (the company?), the sales revenue of recombinant human growth hormone reached 2.889 billion RMB, and the domestic market share was about 70%.

Human Growth Hormone (hGH) is a peptide hormone secreted by the anterior pituitary gland of the human body. It stimulates tissues such as the liver to produce insulin-like growth factor (IGF-1) to exert its physiological functions, promoting bone growth, protein Synthesis, and regulating fat, sugar, mineral metabolism, etc., which plays an important role in human growth and development.

Recombinant human growth hormone has become one of the important products produced by modern biotechnology. At present, it is mainly used for the slow growth of children caused by endogenous growth hormone deficiency, with global sales of approximately $ 5 billion. Based on the current situation, the overall scale of China's recombinant human growth hormone industry is not large compared with developed countries in Europe and the United States, , and the domestic market potential is huge in the future.

In 2018 (the company?), the sales revenue of recombinant human growth hormone reached 2.889 billion RMB, and the domestic market share was about 70%.